Top compounds associated with response to CDH10


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA BRD8899 CTRPv2 pan-cancer AAC -0.022 0.6
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.021 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA hyperforin CTRPv2 pan-cancer AAC 0.022 0.6
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.021 0.6
mRNA salermide CTRPv2 pan-cancer AAC 0.026 0.6
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.02 0.6
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.018 0.6
Download CSV